494 related articles for article (PubMed ID: 17243064)
1. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
[TBL] [Abstract][Full Text] [Related]
2. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
3. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; Morsica G; Pizzaferri P; Ladisa N; Sighinolfi L; Chiodera A; Solmone M; Lalle E; Ippolito G; Monforte Ad; ;
Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
[TBL] [Abstract][Full Text] [Related]
4. Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection.
Mosam A; Sathar MA; Dawood H; Cassol E; Esterhuizen TM; Coovadia HM
AIDS; 2007 Jun; 21(10):1377-9. PubMed ID: 17545721
[TBL] [Abstract][Full Text] [Related]
5. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1.
Smith SM; Donio MJ; Singh M; Fallon JP; Jitendranath L; Chkrebtii N; Slim J; Finkel D; Perez G
Retrovirology; 2005 May; 2():38. PubMed ID: 15927079
[TBL] [Abstract][Full Text] [Related]
7. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
[TBL] [Abstract][Full Text] [Related]
8. Infection with GB virus C and reduced mortality among HIV-infected patients.
Tillmann HL; Heiken H; Knapik-Botor A; Heringlake S; Ockenga J; Wilber JC; Goergen B; Detmer J; McMorrow M; Stoll M; Schmidt RE; Manns MP
N Engl J Med; 2001 Sep; 345(10):715-24. PubMed ID: 11547740
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.
Alcalde R; Nishiya A; Casseb J; Inocêncio L; Fonseca LA; Duarte AJ
Virus Res; 2010 Aug; 151(2):148-52. PubMed ID: 20420864
[TBL] [Abstract][Full Text] [Related]
10. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
Li C; Collini P; Danso K; Owusu-Ofori S; Dompreh A; Candotti D; Opare-Sem O; Allain JP
AIDS; 2006 Feb; 20(3):379-86. PubMed ID: 16439871
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
12. Persistent GB virus C infection and survival in HIV-infected men.
Williams CF; Klinzman D; Yamashita TE; Xiang J; Polgreen PM; Rinaldo C; Liu C; Phair J; Margolick JB; Zdunek D; Hess G; Stapleton JT
N Engl J Med; 2004 Mar; 350(10):981-90. PubMed ID: 14999110
[TBL] [Abstract][Full Text] [Related]
13. GBV-C viremia and clinical events in advanced HIV infection.
Sahni H; Kirkwood K; Kyriakides TC; Stapleton J; Brown ST; Holodniy M;
J Med Virol; 2014 Mar; 86(3):426-32. PubMed ID: 24249700
[TBL] [Abstract][Full Text] [Related]
14. Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women.
Campos AF; Tengan FM; Silva SA; Levi JE
Int J STD AIDS; 2011 Apr; 22(4):209-13. PubMed ID: 21515753
[TBL] [Abstract][Full Text] [Related]
15. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
Björkman P; Flamholc L; Molnegren V; Marshall A; Güner N; Widell A
AIDS; 2007 Jul; 21(12):1641-3. PubMed ID: 17630561
[TBL] [Abstract][Full Text] [Related]
16. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
Hekmat S; Mohraz M; Vahabpour R; Jam S; Bahramali G; Banifazl M; Aghakhani A; Eslamifar A; Mahboudi F; Edalat R; Ramezani A
J Med Virol; 2008 Nov; 80(11):1941-6. PubMed ID: 18814233
[TBL] [Abstract][Full Text] [Related]
17. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study.
Van der Bij AK; Kloosterboer N; Prins M; Boeser-Nunnink B; Geskus RB; Lange JM; Coutinho RA; Schuitemaker H
J Infect Dis; 2005 Mar; 191(5):678-85. PubMed ID: 15688280
[TBL] [Abstract][Full Text] [Related]
18. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.
Zhang W; Chaloner K; Tillmann HL; Williams CF; Stapleton JT
HIV Med; 2006 Apr; 7(3):173-80. PubMed ID: 16494631
[TBL] [Abstract][Full Text] [Related]
19. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
Rodriguez B; Woolley I; Lederman MM; Zdunek D; Hess G; Valdez H
J Infect Dis; 2003 Feb; 187(3):504-7. PubMed ID: 12552436
[TBL] [Abstract][Full Text] [Related]
20. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
